Drug Therapy in Coronary Heart Disease, Especially in the Management of Chronic Myocardial Ischemia

  • P. Lichtlen
Conference paper
Part of the Supplement zu den Sitzungsberichten der Mathematisch-naturwissenschaftlichen Klasse Jahrgang 1988 book series (HD AKAD, volume 1988 / 1988/2)


This presentation deals with the place of drugs in restoring blood flow to the ischemic myocardium. When we talk about ischemia, we must include all ischemic episodes, both silent and symptomatic ones. Recent technical improvements today allow recording ST-segment changes beat-to-beat continuously over 24 h. Many studies have demonstrated that most ischemic episodes are silent, that is, not accompanied by pain.


Calcium Antagonist Coronary Flow Reserve Plaque Rupture Vasomotor Tone Ischemic Episode 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gould KL, Lipscomb K (1974) Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 34: 48–55PubMedCrossRefGoogle Scholar
  2. 2.
    Lichtlen PR (1985) Pathophysiology of coronary and myocardial function in angina pectoris: important aspects for drug treatment. Eur Heart J 6 Suppl F: 11–25CrossRefGoogle Scholar
  3. 3.
    Lichtlen PR (1988) The combination of antianginal drugs: effects and indications. Cardiovasc Drugs Ther (in press)Google Scholar
  4. 4.
    Heusch G, Guth BD, Seitelberger R, Ross J (1987) Attenuation of exercise-induced myocardial ischemia in dogs with recruitment of coronary vasodilator reserve by nifedipine. Circ 75: 482–490CrossRefGoogle Scholar
  5. 5.
    Rafflenbeul W, Lichtlen PR (1982) Zum Konzept der „dynamischen“ Koronarstennse. Z Kardiol 71: 439–444PubMedGoogle Scholar
  6. 6.
    Schaper J, Alpers P, Gottwick M, Schaper W (1985) Ultrastructural characteristics of regional ischemia and infarction in the canine heart. Eur Heart J 6 Suppl E: 21–31CrossRefGoogle Scholar
  7. 7.
    Reimer KA, Jennings RB (1985) Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction. Am J Cardiol 55: 107B - 115BPubMedCrossRefGoogle Scholar
  8. 8.
    Lewis HD, Davis JW, Archibald WE et al. (1983) Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 309: 396–403PubMedCrossRefGoogle Scholar
  9. 9.
    Krayenbühl HP, Hirzel H, Hess OM, Schneider J, Turina M (1987) Hemodynamics of painless ischemia. In: von Arnim T, Maseri A (eds) Silent myocardial ischemia. Steinkopff, Darmstadt, Springer, New York, pp 147–151Google Scholar
  10. 10.
    Aversano T, Becker LC (1985) Persistence of coronary vasodilator reserve despite functionally significant flow reduction. Am J Physiol 248: H403 - H411PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • P. Lichtlen

There are no affiliations available

Personalised recommendations